We argue that LDL’s impact on inhibiting tumor cell proliferation by reducing ox-LDL or LOX-1 levels and enhancing specific molecular pathways significantly outweighs its role as a nutrient for cancer cells. The gene discussed is OLR1; the disease is neoplasm.